Aikaterini Theodorou
Overview
Explore the profile of Aikaterini Theodorou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsivgoulis G, Katsanos A, Romoli M, Sarraj A, Krogias C, Karapanayiotides T, et al.
J Neurol Neurosurg Psychiatry
. 2025 Mar;
PMID: 40089306
Background: Current international guidelines suggest andexanet alfa (AA) for the management of factor Xa inhibitor-associated intracranial haemorrhage (ICH). However, those recommendations are based on low-quality evidence and there is uncertainty...
2.
Stefanou M, Panagiotopoulos E, Palaiodimou L, Theodorou A, Magoufis G, Spiliopoulos S, et al.
Eur Stroke J
. 2025 Mar;
:23969873251324863.
PMID: 40079576
Introduction: Evidence on endovascular therapy (EVT) for symptomatic intracranial stenosis (sICAS) from randomized-controlled clinical trials (RCTs) is conflicting. While prior RCTs on percutaneous transluminal angioplasty and stenting (PTAS) demonstrated harm...
3.
Stefanou M, Katsaros V, Pepe G, Theodorou A, Stefanou D, Koropouli E, et al.
J Clin Neurol
. 2025 Mar;
21(2):153-155.
PMID: 40065458
No abstract available.
4.
Filippatou A, Theodorou A, Stefanou M, Tzanetakos D, Kitsos D, Moschovos C, et al.
J Neurol Sci
. 2025 Feb;
470:123422.
PMID: 39954575
Background And Objectives: Anterior visual pathway involvement is common in multiple sclerosis (MS) and optical coherence tomography (OCT) can be utilized to examine the integrity of the ganglion cell axons...
5.
Giannopapas V, Smyrni V, Kitsos D, Stefanou M, Theodorou A, Tzartos J, et al.
J Neurol
. 2025 Jan;
272(2):162.
PMID: 39849174
Introduction: The current literature on the prevalence and potential association between disease-modifying therapies (DMTs) and cancer risk in the MS population has yielded mixed findings. Methods: This study aimed to...
6.
Sterpi A, Triantafyllou A, Tzanetakos D, Ampantzi E, Kitsos D, Theodorou A, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768480
Radiotherapy (RT) remains crucial in treating both primary and metastatic central nervous system cancer. Despite advancements in modern techniques that mitigate some toxic adverse effects, magnetic resonance imaging (MRI) scans...
7.
Keramida A, Theodorou A, Merkouri F, Tsiodras S, Tsivgoulis G
Acta Neurol Belg
. 2024 Dec;
PMID: 39690400
No abstract available.
8.
Theodorou A, Athanasaki A, Melanis K, Pachi I, Sterpi A, Koropouli E, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685885
Cognitive impairment represents a core and prodromal clinical feature of cerebral amyloid angiopathy (CAA). We sought to assess specific cognitive domains which are mainly affected among patients with CAA and...
9.
Panagiotopoulos E, Stefanou M, Magoufis G, Safouris A, Kargiotis O, Psychogios K, et al.
Neurol Res Pract
. 2024 Nov;
6(1):54.
PMID: 39523357
Background: Intracranial atherosclerotic disease (ICAD) represents a leading cause of ischemic stroke worldwide, conferring increased risk of recurrent stroke and poor clinical outcomes among stroke survivors. Emerging evidence indicates a...
10.
Fanouraki S, Theodorou A, Velonakis G, Stavrinou L, Papadavid E, Tzartos J, et al.
Neurology
. 2024 Oct;
103(10):e209983.
PMID: 39442061
Evaluating patients with neuropathy is common, especially in elderly patients with comorbidities. Neuropathy can often be a manifestation of systemic diseases, cancer, or drug-induced toxicity; thus, the differential diagnosis is...